MICHELLE ASSEO: Open Payments
NPI 1841077500 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 96 payments from 17 companies in 2025. Trend: 2023 $117 · 2024 $1,841 · 2025 $2,113
Food & beverage: $2,062Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $726 |
| Janssen Biotech, Inc. | 23 | $447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $195 |
| Lilly USA, LLC | 6 | $130 |
| Ardelyx, Inc. | 4 | $86 |
| Madrigal Pharmaceuticals | 4 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $64 |
| Intercept Pharmaceuticals, Inc. | 2 | $53 |
Products named: TREMFYA, CREON, RINVOQ, ENTYVIO, LINZESS, OMVOH, IBSRELA, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
